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Abstract
Aim The objective of this study was to investigate the effect of implementation of short-term patient empowerment as
applied to Mediterranean diet (MD) adherence on metabolic and anthropometric parameters in prediabetic overweight or
obese subjects.
Methods The sample included 42 subjects with prediabetes, aged 18–75 years and with bodymass index (BMI) > 25 kg/m2, who
received dietary advice on MD by nutritionists during session groups every 2 weeks for 4 months. Data on energy caloric intake
and macronutrient consumption were collected using a 7-day food diary record. Adherence to MD was investigated through the
PREvención con DIeta MEDiterránea (PREDIMED) questionnaire. No advice was given regarding caloric restriction and
physical activity. At baseline and at the end of the study, each subject underwent anthropometric, metabolic, and nutritional
assessments.
Results Approximately 40.5% of subjects had achieved restoration of normal glucose tolerance by the end of the study.
Fasting plasma glucose, glycated hemoglobin (HbA1C), BMI, waist circumference, blood pressure, visceral adiposity
index, triglycerides, and total and LDL cholesterol levels were significantly decreased, while HDL cholesterol had
significantly increased by the end of the study. The subjects significantly increased adherence to MD, as assessed by
the PREDIMED questionnaire at follow-up. A reduction of prevalence of the metabolic syndrome was also reported.
Interestingly, the PREDIMED score correlated with HbA1C values at follow-up, after adjusting for BMI and total caloric
intake.
Conclusions Implementation of short-term patient empowerment as applied to MD adherence was shown to improve anthropo-
metric and metabolic parameters in prediabetic overweight or obese subjects. This is of considerable importance, given that diet
must be the cornerstone of treatment in patients at high risk of developing type 2 diabetes.
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Introduction
Prediabetes is associated with increased risk of type 2 diabetes
and diabetic-related complications, such as cardiovascular dis-
eases [1]. The Diabetes Prevention Program (DPP) [2] and
ACT NOW [3] studies have reported that the rate of conver-
sion of prediabetes to type 2 diabetes is 7–10% per year, with
no significant difference in ethnicity. The most important ther-
apeutic strategy to prevent progression from prediabetes to
overt type 2 diabetes is lifestyle intervention focused on phys-
ical activity and a healthy diet. However, there is no specific
dietary pattern recommendation to prevent type 2 diabetes in
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either the general or the at-risk population. The American
Diabetes Association recommends dietary strategies that de-
crease calories and intake of dietary fat, while it encourages
the intake of dietary fiber and foods containing whole grains
as well as the reduction of sugar intake, e.g., sweetened bev-
erages [4]. Studies have reported healthful diets to be effective
in the reduction of type 2 diabetes, although the dietary pat-
terns used in these studies were very heterogeneous, thus not
permitting any firm conclusions to be drawn [5]. The
Mediterranean diet (MD) seems to be a promising approach
to fight diabetes at new diagnosis, even without caloric restric-
tion. The healthy dietary pattern of the Mediterranean diet is
characterized by high consumption of vegetables, legumes,
grains, fruits, nuts, and olive oil; moderate consumption of
fish and wine; and low consumption of red and processed
meat and whole-fat dairy products [6]. Lower incidence of
type 2 diabetes has been observed with increasing adherence
to MD in Southern Europe [7]. Furthermore, better glycemic
control and a delay in starting antidiabetic drugs have been
observed in diabetic subjects following MD compared to sub-
jects following a low-fat diet [8]. The PREvención con DIeta
MEDiterránea (PREDIMED) study compared the long-term
effect of MD plus virgin olive oil or nuts with a low-fat diet on
the incidence of type 2 diabetes. Although caloric restriction
was not recommended, MD has been reported to be effective
in the prevention of diabetes [9]. In particular, MD is recom-
mended by the American Diabetes Association (ADA) due to
its beneficial effects on glycemic control and cardiovascular
risk factors, but only as an alternative to a lower fat, higher
carbohydrate eating pattern [9]. A systematic review with
meta-analyses on the efficacy of MD on the management of
type 2 diabetes and prediabetic states indicated that MD was
associated with better glycemic control and cardiovascular
risk factors than control diets, including a lower fat diet, thus
suggesting that it is suitable for the overall management of
type 2 diabetes [10].
In addition, another important tool that could be a
promising approach to tackle prediabetes is the empower-
ment of patients regarding the lifestyle to be adopted.
Empowerment has long been considered an important
and integral component of management of diabetes [11].
Diabetic self-management education, whether delivered
on an individual basis or in a group setting, has been
shown to improve glycemic control and cardiovascular
risk factors [12, 13].
Based on the results of the PREDIMED study, we aimed
to investigate the short-term effect of MD on metabolic
control in prediabetic overweight or obese subjects.
Given the paramount importance of empowerment in the
management of type 2 diabetes, we decided to deliver
knowledge on MD to patients through informative talks
with nutritionists, with the aim of empowering prediabetic
subjects regarding this dietary pattern.
Materials and methods
Study design and participants
This study was part of a health promotion intervention funded
by the National Center for Prevention and Control of Diseases
of the Italian Ministry of Health 2010. The study design was a
4-month pilot study carried out in participants with prediabe-
tes with overweight or obesity, investigating the short-term
effect of MD on metabolic parameters. The subjects were
enrolled in different Diabetes Outpatient Clinics in the metro-
politan area of Naples, which were coordinated by the Unit of
Endocrinology of the Dipartimento di Medicina Clinica e
Chirurgia, at the University “Federico II” of Naples, Italy,
and included 42 participants. The work was conducted in ac-
cordance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involv-
ing humans and was approved by the Ethical Committee of
the University of Naples “Federico II”Medical School (n. 05/
14). The purpose of the protocol was explained to all patients,
and written informed consent was obtained. The study was
conducted without support from the pharmaceutical industry.
Eligible participants for the study were adult subjects (aged
18–75 years) with prediabetes, diagnosed according to
glycated hemoglobin (HbA1c) recommended by the ADA
guidelines (5.7–6.4%) [4] and BMI > 25 kg/m2, who were
not taking any antidiabetic drugs, without cardiovascular dis-
eases, without clinical events, and with no other serious dis-
eases. Participants with overt type 2 diabetes were excluded.
Other exclusion criteria were alcohol or drug abuse and histo-
ry of allergy or intolerance to olive oil.
Procedures
Trained nutritionists were responsible for all aspects of the
behavioral intervention promoting MD. Briefly, nutritionists
gave dietary advice to participants by holding session groups
every 2 weeks for 4 months. The sessions consisted of infor-
mative talks on MD, without offering any advice on energy
restriction and without promoting physical activity. The gen-
eral recommendations for MD were as follows: use of extra
virgin olive oil for cooking and dressing of salads and other
dishes; consumption of two or more servings (125 g/serving)
per day of vegetables (at least one of them as salad); three or
more servings per day of fresh fruit; three or more servings per
week of legumes; three or more servings per week of fish or
seafood; three or more servings per week of nuts or seeds;
white meats instead of red meats or processed meats; and
regular preparation of a homemade sauce with tomato, garlic,
onion, and spices with olive oil to dress vegetables, pasta, rice,
and other dishes. Optionally, among alcohol drinkers, moder-
ate consumption of red wine (seven glasses/week) was also
allowed. Recommendations were also given to avoid or limit
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the consumption of butter, cream, fast food, sweets, pastries,
and sugar-sweetened beverages.
Adherence to MD
As already reported [14], adherence to MD was evaluated
using the previously validated 14-item questionnaire for the
assessment of PREDIMED [15]. A qualified nutritionist ad-
ministered the questionnaire during a face-to-face interview
with all enrolled subjects. Briefly, for each item, scores 1
and 0 were assigned; the PREDIMED score was calculated
as follows: score 0–5, lowest adherence; score 6–9, average
adherence; and score ≥ 10, highest adherence [15].
Dietary assessment
As previously reported [6], data were obtained during a face-
to-face interview between the patient and a qualified nutrition-
ist. Dietary assessment data were collected using a 7-day food
record [16, 17]. The dietary interview enabled quantification
of foods and drinks by using a photographic food atlas (≈
1000 photographs) of known portion sizes to ensure accurate
completion of the records [18]. On day 1 of the diary, the
nutritionists, trained in standardized protocols, provided par-
ticipants with instructions on how to complete the diary at the
health check and asked them to recall the previous day’s in-
take. Participants prospectively completed the remaining
6 days. The subjects returned the records to the nutritionist,
who asked supplemental questions if necessary. Data were
stored and processed using commercial software (Terapia
Alimentare Dietosystem® DS-Medica, http://www.
dsmedica.info). As regards quantities and qualities of foods
consumed, the software is able to calculate not only the daily
caloric intake but also the quantities of macronutrients
(protein; total, complex, and simple carbohydrates; fibers;
total fat, saturated fatty (SFA), monounsaturated fatty acids
(MUFA), polyunsaturated fatty acids (PUFA): n-6 PUFA, n-
3 PUFA, and n-6/n-3 PUFAs ratio; and cholesterol).
Anthropometric measurements
All anthropometric measurements were taken with subjects
wearing light clothes and without shoes. In each subject, body
mass index (BMI) was calculated as weight (kg)/height (m2).
Height was measured to the nearest 1 cm using a wall-
mounted stadiometer. Body weight was determined to the
nearest 100 g using a calibrated balance beam scale. Waist
circumference (WC) was measured to the closest 0.1 cm with
a non-extensible tape. The measurements were made with the
subject standing upright, feet together, arms hanging freely at
the sides, and breathing normally. WC was measured at the
midpoint between the inferior costal margin and the upper
iliac crest. Hip circumference (HC) was measured as the
maximum circumference around the buttocks posteriorly and
the symphysis pubis anteriorly and measured to the nearest
0.5 cm. In all individuals, systolic (SBP) and diastolic (DBP)
blood pressures were measured three times, 2 min apart, with
a random zero sphygmomanometer (Gelman Hawksley Ltd.,
Sussex, UK) after the subject had been sitting for at least
10 min. The average of the second and third readings was
recorded.
Physical activity level was investigated with a standard
questionnaire and was expressed according to whether the
participant habitually engaged at least 30 min/day of aerobic
exercise (YES/NO).
Laboratory tests
Venous blood samples were taken from the antecubital vein
between 8 and 10 a.m. after an overnight fast of at least 8 h,
collected in vacutainer tubes containing EDTA, and stored at
− 80 °C until processed. All biochemical analyses, including
total cholesterol and triglycerides, were performed with a
Roche Modular Analytics System in the Central
Biochemistry Laboratory of our Institution. Low-density lipo-
protein (LDL) cholesterol and high-density lipoprotein (HDL)
cholesterol were determined by direct method (homogeneous
enzymatic assay for the direct quantitative determination of
LDL cholesterol and HDL cholesterol). Fasting plasma glu-
cose concentration was measured by the glucose oxidase
method. HbA1c was measured with high-performance liquid
chromatography (HPLC). The intra-assay coefficients of var-
iations (CV) were < 5.5%.
Visceral adiposity index
The visceral adiposity index (VAI) was calculated with the
following sex-specific formula, with TG levels expressed in
millimoles per liter and HDL levels expressed in millimoles
per liter [19, 20]:
Male
VAI ¼ WC
39:68þ 1:88 BMIð Þ
 
 TG
1:03
 
 1:31
HDL
 
Female
VAI ¼ WC
36:58þ 1:89 BMIð Þ
 
 TG
0:81
 
 1:52
HDL
 
Criteria defining metabolic syndrome
According to the National Cholesterol Education Program
(NCEP)-Adult Treatment Panel (ATP III) definition, metabol-
ic syndrome (MetS) is present if three or more of the following
five criteria are met:WC over 102 cm and 88 cm (in males and
females, respectively), blood pressure over 130/85 mmHg,
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fasting triglyceride level over 150 mg/dL, fasting HDL cho-
lesterol level less than 40 mg/dL and 50 mg/dL (in males and
females, respectively), and fasting glucose over 100 mg/dL
(NCEP-ATP III 2000).
Outcomes
The main outcome of interest was changes of HbA1c values
after a mean of 4 months of follow-up. Changes in anthropo-
metric measurements, blood pressure, fasting plasma glucose,
lipid profile, and total energy, as well as the daily macronutri-
ent intake and adherence to MD at the end of intervention,
were pre-specified secondary outcomes in this study.
Statistical methods
Data are expressed as mean ± SD or as median plus
range according to variable distributions evaluated by
the Kolmogorov-Smirnov test. Differences between the
two groups were analyzed by the Wilcoxon paired test
or Student’s paired t test, when appropriate. The chi-
square (χ2) test was used to test the significance of
differences in frequency distributions. The correlations
between variables were performed using Pearson r or
Spearman’s rho correlation coefficients, when appropri-
ate. Univariate proportional odds ratio (OR) models,
95% confidence interval (IC) and adjusted R2, were per-
formed to assess the association among quantitative var-
iables (all food items of the PREDIMED questionnaire
as YES and NO, and PREDIMED score as low, aver-
age, and high adherence). In these analyses, we entered
only those variables that had a P value < 0.05 in the
univariate analysis (partial correlation). To avoid
multicollinearity, variables with a variance inflation fac-
tor (VIF) > 10 were excluded. Values ≤ 0.05 were con-
sidered statistically significant. Data were stored and
analyzed using the MedCalc® package (Version 12.3.0
1993–2012 MedCalc Software bvba-MedCalc Software,
Mariakerke, Belgium). Since there were no similar stud-
ies in the literature, we performed a priori sample size
calculations using G POWER software.
Results
Subject characteristics
All participants in the study completed the PREDIMED ques-
tionnaires and the 7-day food records. The resulting total sam-
ple size, estimated according to a global effect size of 0.8 with
type I error of 0.05 and a power of 95%, is 35 subjects in each
group. Thus, we decided to enroll 42 subjects in each group,
adjusting the sample size for 20% anticipated dropouts.
The study population, aged 60.5 (37.0–71.0) years,
consisted of 21 females (50%). The mean of BMI was
32.23 ± 6.08 kg/m2.
The baseline anthropometric measurements, blood pres-
sure, fasting plasma glucose (FPG) and HbA1c, lipid profile,
VAI, and physical activity of each participant are reported in
Table 1. In particular, WCwas higher than sex-specific cutoffs
in 90.5% (38 subjects). Physical activity on at least 5 days per
week was reported in 59.5% (25 subjects).
Figure 1 shows that in the case of prevalence of single
metabolic risk factors and MetS, fasting glucose was higher
than specific cutoffs in 81.0% (34 subjects), while presence/
absence of MetS was diagnosed in 54.8% (23 subjects).
Response frequency of dietary components included in the
PREDIMED questionnaire of the subjects at baseline is re-
ported in Table 2. Extra virgin olive oil was the most con-
sumed food item (71.4%), followed by fish (57.1%).
According to the PREDIMED score, a large percentage of
subjects demonstrated average adherence (PREDIMED score
6–9) to MD (57.1%, 24 subjects) (Fig. 2). In Table 3, we
report total energy and daily macronutrient intakes obtained
from the 7-day food records.
The results of the univariate proportional odds ratio model,
performed to assess the association of percentage of HbA1c
with food items of the PREDIMED questionnaire, are report-
ed in Table 4. The components of MD that were the major
determinants of HbA1C were extra virgin olive oil (P =
0.025), vegetables (P = 0.007), fruit (P = 0.048), legumes
(P < 0.001), fish (P = 0.028), and nuts (P < 0.001), whose con-
sumption seems to have a beneficial effect on HbA1C values.
By contrast, the highest odds of consumption of red meats
(P = 0.017), butter (P = 0.028), soda drinks (P = 0.007), and
commercial sweets and confectionery (P = 0.023) seemed to
have a negative effect on HbA1C values. In addition, the
higher score of adherence to MD was negatively associated
with percentage of HbA1c (r = − 0.564, P < 0.001), indepen-
dently of BMI and total energy intake (r = − 0.501,P = 0.001).
Follow-up results
Seventeen subjects (40.5%) achieved restoration of normal
glucose tolerance by the end of the study.
After the 4-month dietary intervention, there was a signif-
icant decrease of both HbA1C (P < 0.001) and FPG
(P < 0.001) (Table 1).
Figure 1 shows the difference of the prevalence in the sin-
gle metabolic risk factors and MetS after 4 months of follow-
up. BMI, WC, SBP/DBP, VAI, and total and LDL cholesterol
levels were significantly decreased, while HDL cholesterol
had significantly increased by the end of the study (P
< 0.001). In addition, there was a significant reduction in
triglycerides (P = 0.027), and the subjects exhibited statistical-
ly significant differences compared with baseline for MetS
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presence/absence (P = 0.049). No difference was found in
terms of physical activity (P = 0.056).
Considering the response frequency of dietary components
included in the PREDIMED questionnaire, statistically signif-
icant differences were observed (Table 2). In particular, the
subjects had increased consumption of vegetables (P =
0.003), legumes (P = 0.001), fish/seafood (P = 0.033), nuts
(P < 0.001), and poultry (P = 0.001) and had reduced con-
sumption of red/processed meats, butter, cream, margarine,
soda drinks, commercial sweets, and confectionery
(P < 0.001). In addition, the PREDIMED score was increased
(6.21 ± 1.85 vs. 10.52 ± 2.31, P < 0.001), and, as shown in
Fig. 2, the percentage of subjects with a high adherence to
MD (PREDIMED score ≥ 10) was significantly increased
(4.8 vs. 73.8%; χ2 = 39.13, P < 0.001).
Table 3 shows the differences of total energy and daily
macronutrient intakes. The subjects experienced a significant
reduction in total energy intake (P < 0.001). In addition, all
daily macronutrient intake was modified after 4 months,
resulting in a significantly increased consumption of fiber
(P < 0.001) and a significant decrease of simple carbohydrates
(P < 0.001), fat (P < 0.001), and cholesterol (P < 0.001). No
changes were recorded regarding the consumption of protein
(P = 0.347), while a trend toward a positive association with
complex carbohydrates was observed (P = 0.086).
The components of MD that were the major determinants
of HbA1C were extra virgin olive oil (P = 0.02), vegetables
(P = 0.015), legumes (P = 0.015), fish (P = 0.006), and nuts
(P = 0.022), whose consumption seems to have a beneficial
effect on HbA1C values. In contrast, the highest consumption
of red meats (P = 0.044), soda drinks (P = 0.008), and com-
mercial sweets and confectionery (P = 0.014) seemed to have
a negative effect on HbA1C values (Table 4). As expected,
delta variations of HbA1c correlated with delta variations of
total energy and daily macronutrient intakes obtained from the
7-day food records, except for n-3 PUFA (P = 0.498) after
4 months of follow-up (Table 5). Figure 3 shows the correla-
tion between delta variations of HbA1c and delta variations of
PREDIMED score at 4 months of follow-up (r = 0.552,
P < 0.001).
As already noted at baseline, the higher score of adherence
to MD was negatively associated with a lower percentage of
HbA1c (r = − 0.919, P < 0.001), independently of BMI and
total energy intake (r = − 0.799, P < 0.001).
Discussion
In this nutrition intervention study, we found that a non-calo-
rie-restricted, traditional MD decreased HbA1C values in
Table 1 Clinical and metabolic
characteristics of the subjects at
baseline and after 4 months of
dietary intervention
Parameters Baseline
n = 42
After 4 months
n = 42
P value
BMI (kg/m2) 32.23 ± 6.08 30.60 ± 5.79 < 0.001
WC (cm) 104.55 (89.0–133.0) 100.0 (87.0–130.2) < 0.001
HC (cm) 106.00 (72.1–136.5) 108.05 (78.0–139.0) 0.361
SBP (mmHg) 130.00 (100.0–155.0) 120.00 (90.0–140.0) < 0.001
DBP (mmHg) 85.00 (60.0–95.0) 70.00 (60.0–85.0) < 0.001
Fasting glucose (mg/dL) 125.36 ± 15.26 115.60 ± 12.54 < 0.001
HbA1c (%) 6.30 (6.0–6.5) 5.85 (5.3–6.8) < 0.001
Total cholesterol (mg/dL) 187.62 ± 42.63 174.76 ± 39.21 < 0.001
HDL cholesterol (mg/dL) 45.00 (26.0–80.0) 51.00 (35.0–78.0) < 0.001
LDL cholesterol (mg/dL) 107.97 ± 37.43 94.45 ± 33.49 < 0.001
Fasting triglycerides (mg/dL) 166.00 (57.0–443.0) 146.00 (58.0–253.0) 0.027
VAI 5.86 (1.41–17.02) 4.18 (1.69–10.89) 0.001
Physical activity
Yes 25 (59.5%) 34 (81.0%) 0.056
No 17 (40.5%) 8 (19.0%)
After 4 months, the patients exhibited statistically significant differences compared with baseline for anthropo-
metric measurements, metabolic profiles, and cardiometabolic indices. Data are expressed as mean ± SD or as
median plus range according to variable distributions evaluated by the Kolmogorov-Smirnov test. The paired t test
orWilcoxon paired test was used for the significance differences between the two groups. The chi-square (χ2 ) test
was used to test whether groups were associated with physical activity. A P value in italics denotes a significant
difference (P < 0.05)
BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP,
diastolic blood pressure; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
VAI, visceral adiposity index
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prediabetic subjects with overweight or obesity after a median
follow-up of 4 months. The improvement of HbA1C values
was accompanied by a significant reduction in all anthropo-
metric measurements, blood pressure, lipid profile, and VAI,
and a significant increase in HDL cholesterol. At the end of
the study, prediabetic subjects were found to have increased
adherence to MD and a significant change in food cues, pre-
ferring vegetables, legumes, fish/seafood, nuts, and poultry to
red/processed meats, butter, cream, margarine, soda drinks,
and commercial sweets and confectionery. Our results confirm
previous studies highlighting the role of change of lifestyle as
a key player in the management of prediabetes [11–13]. In our
study, the nutritionists provided knowledge on MD, thus
empowering prediabetic subjects in awareness of what consti-
tutes a healthy diet, such as MD, as a key component in/an
essential part of prediabetes management. As previously re-
ported, patient empowerment is of paramount importance in
diabetes education, increasing diabetic individuals’ knowl-
edge concerning self-care, skills, self-awareness, and the sense
of personal autonomy [21]. Usually, diagnosis of type 2
diabetes arouses a range of emotional responses that threaten
people’s social and personal identity; thus, there is the need to
construct new identity representations. Raballo et al. investi-
gated the perceptions of diabetes care and diabetes in a large
cohort of Italian patients followed long term by group or usual
care [22]. These authors developed and validated an educa-
tional model, reporting that group treatment was effective in
reinforcing communication and peer identification, and sug-
gested that it can be applied to everyday practice in busy
diabetes clinics. In particular, their educational model
achieved its clinical aims by promoting awareness, self-effi-
cacy, positive attitudes toward diabetes and the setting of care,
an internal locus of control, and empowerment in the patients.
In China, diabetic subjects enrolled in an empowerment-based
self-management program, improved diet management and
blood glucose self-monitoring [23]. A cluster-randomized
clinical trial was carried out in people with type 2 diabetes
participating in seven group meetings, each one lasting around
2 h. At the end of the study, there was an improvement in
glycemic levels, as demonstrated by glycated hemoglobin
Fig. 1 Frequency of metabolic risk factors and MetS in patients at
baseline and after 4 months. After 4 months, the patients exhibited
statistically significant differences compared with baseline for some
parameters of the MetS. In particular: WC (90.5 vs. 69.0%; χ2 = 4.72,
P = 0.030), SBP/DBP (54.8 vs. 21.4%; χ2 = 8.53, P = 0.004),
triglycerides (64.3 vs. 42.9%; χ2 = 3.06, P = 0.080), HDL-C (50.0 vs.
21.4%; χ2 = 6.27, P = 0.012); fasting glucose (81.0 vs. 59.5%; χ2 =
3.65, P = 0.056), and MetS presence/absence (57.1 vs. 33.3%; χ2 =
3.89, P = 0.049) at baseline and after 4 months, respectively. Data are
expressed as percentage. The chi-square (χ2) test was used to test the
significance of differences between the two groups. A P value in bold
type denotes a significant difference (P < 0.05).WC, waist circumference;
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C,
high-density lipoprotein cholesterol; MetS, metabolic syndrome
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results [24]. Accordingly, in our study also, empowerment has
been proven to reinforce the motivation of diabetic subjects
and the ability to believe in themselves, thus reducing the
stress related to the inability of managing the disease.
Furthermore, all the subjects enrolled in our study lived in
the same metropolitan area, therefore sharing similar food
habits. As result of empowerment, they were enabled to
change their food habits in a healthy way, using foods and
recipes that, in fact, already belong to their own nutritional
tradition. Since, as mentioned, all the subjects lived in the
same area, they switched their dietary pattern to the intake of
similar food, thus reducing possible bias.
Table 2 Response frequency of dietary components included in the PREDIMED questionnaire at baseline and after 4 months
Questions Baseline
n = 42
After 4 months
n = 42
P values
n % n %
1 Use of extra virgin olive oil as main culinary lipid 30 71.4 30 71.4 0.809
2 Extra virgin olive oil > 4 tablespoons 21 50.0 22 52.4 1.000
3 Vegetables ≥ 2 servings/day 20 47.6 34 81.0 0.003
4 Fruits ≥ 3 servings/day 18 42.9 27 64.3 0.080
5 Red/processed meats < 1/day 21 50.0 35 83.3 < 0.001
6 Butter, cream, margarine < 1/day 18 42.9 39 92.9 < 0.001
7 Soda drinks < 1/day 10 23.8 36 85.7 < 0.001
8 Wine—glasses ≥ 7/week 12 28.6 18 42.9 0.255
9 Legumes ≥ 3/week 20 47.6 37 88.1 0.001
10 Fish/seafood ≥ 3/week 24 57.1 34 81.0 0.033
11 Commercial sweets and confectionery ≤ 2/week 11 26.2 37 88.1 < 0.001
12 Tree nuts ≥ 3/week 13 31.0 35 83.3 < 0.001
13 Poultry more than red meats 21 50.0 36 85.7 0.001
14 Use of sofrito sauce ≥ 2/week 22 52.4 27 64.3 0.376
After 4 months, most of the questions of the PREDIMED questionnaire were answered positively. Data are expressed as percentage of response obtained
with the PREDIMED questionnaire. PREDIMED, PREvención con DIetaMEDiterránea [9]
Fig. 2 Difference of adherence
MD in the PREDIMED score at
baseline and after 4 months. After
4 months, the patients exhibited
statistically significant differences
compared with baseline for the
adherence MD in the
PREDIMED score. In particular:
low adherence of MD (38.1 vs.
4.8%; χ2 = 11.95, P = 0.001),
average adherence of MD (57.1
vs. 21.4%; χ2 = 9.78, P = 0.002),
and higher adherence of MD (4.8
vs. 73.8%; χ2 = 39.13, P < 0.001)
at baseline and after 4 months,
respectively. Data are expressed
as percentages
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The patients’ increased knowledge ofMD resulted not only
in food restriction but also in the switch to healthier food
preferences. As a result, the subjects experienced an improve-
ment in HbA1C values, which, notably, was partially ex-
plained by weight loss. In fact, a higher score of adherence
to MD was inversely associated with percentage of HbA1c,
after adjusting for BMI and total energy intake, thus suggest-
ing that the MD food cluster could have beneficial metabolic
properties besides weight loss. This assumption was support-
ed by the fact that most of the components of MD share anti-
oxidant properties due to polyphenols. Olive oil, nuts, red
wine, legumes, fruits, and vegetables, key MD components,
are all polyphenol-rich foods that have been reported to have
beneficial effects on glucose metabolism [25]. The consump-
tion of olive leaf extract (500 mg) resulted in a significant
decrease of HbA1C and fasting plasma insulin levels in type
2 diabetic subjects [26]. Similar results were found by de Bock
et al., who demonstrated an improvement of pancreatic β-cell
function and insulin resistance after olive oil administration in
middle-aged overweight men [27]. In addition, one of the
main characteristics of traditional MD is the moderate intake
of wine consumed with meals. Wine, particularly red wine, is
Table 3 Total energy and
macronutrient intake of patients at
baseline and after 4 months
Parameters Baseline
n = 42
After 4 months
n = 42
P value
Total energy (kcal) 2512.07 ± 501.64 2238.21 ± 564.80 < 0.001
Protein (g of total kcal) 98.23 ± 17.25 94.47 ± 22.72 0.347
Carbohydrate (g of total kcal) 345.49 ± 78.50 304.79 ± 76.93 < 0.001
Complex (g of total kcal) 208.83 ± 50.15 203.72 ± 51.67 0.086
Simple (g of total kcal) 136.67 ± 34.16 101.07 ± 25.36 < 0.001
Fiber (g/day) 16.27 ± 5.56 19.30 ± 4.19 < 0.001
Fat (g of total kcal) 81.90 ± 21.69 71.24 ± 19.17 < 0.001
SFA (g of total kcal) 33.40 ± 10.53 23.35 ± 6.03 < 0.001
MUFA (g of total kcal) 28.27 ± 7.62 31.78 ± 8.45 0.021
PUFA (g of total kcal) 20.40 ± 15.56 16.12 ± 14.09 0.015
n-6 PUFA (g/day) 17.79 ± 15.82 12.89 ± 14.31 0.005
n-3 PUFA (g/day) 2.61 ± 0.80 3.22 ± 1.26 0.006
n-6/n-3 PUFAs ratio 7.92 ± 8.24 4.76 ± 6.42 0.004
Cholesterol (mg/day) 155.93 ± 50.32 135.48 ± 38.38 < 0.001
Table 4 Univariate proportional odds ratio model to assess the association between circulating levels of HbA1c and food items included in the
PREDIMED questionnaire
Questions Baseline After 4 months
OR P value 95% IC R2 OR P value 95% IC R2
1 Use of extra virgin olive oil as main culinary lipid 0.004 0.025 0.001–0.490 0.138 0.032 0.002 0.003–0.292 0.269
2 Extra virgin olive oil > 4 tablespoons 0.528 0.721 0.016–17.61 0.003 0.064 0.005 0.009–0.445 0.217
3 Vegetables ≥ 2 servings/day 0.003 0.007 0.001–0.205 0.188 0.105 0.015 0.017–0.641 0.153
4 Fruits ≥ 3 servings/day 0.021 0.048 0.001–0.974 0.096 0.209 0.060 0.041–1.065 0.088
5 Red/processed meats < 1/day 132.66 0.017 2.384–7381.08 0.144 0.112 0.044 0.013–0.940 0.104
6 Butter, cream, margarine < 1/day 91.94 0.028 1.641–5153.47 0.123 0.001 0.110 0.001–18.962 0.276
7 Soda drinks < 1/day > 999.00 0.007 22.42–> 999.0 0.281 0.002 0.008 0.001–0.206 0.323
8 Wine—glasses ≥ 7/week 0.149 0.341 0.003–7.515 0.022 0.211 0.107 0.032–1.396 0.069
9 Legumes ≥ 3/week 0.001 < 0.001 0.000–0.001 0.538 0.002 0.015 0.001–0.307 0.288
10 Fish/seafood ≥ 3/week 0.011 0.028 0.000–0.610 0.123 0.001 0.006 0.000–0.087 0.462
11 Commercial sweets and confectionery ≤ 2/week 394.34 0.023 2.249–> 999 0.145 0.012 0.014 0.001–0.416 0.214
12 Tree nuts ≥ 3/week 0.001 < 0.001 0.000–0.001 0.504 0.120 0.022 0.020–0.732 0.134
13 Poultry more than red meats 0.103 0.217 0.003–3.797 0.037 0.243 0.185 0.030–1.969 0.042
14 Use of sofrito sauce ≥ 2/week 0.025 0.058 0.001–1.133 0.089 0.400 0.327 0.064–2.505 0.023
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rich in phenolic compounds, including flavonoids (anthocya-
nins, tannins, and catechins), stilbenes like resveratrols,
tyrosols, and hydroxytyrosols. Evidence suggests that red
wine is rich in polyphenols that are responsible for improve-
ment in insulin resistance, as measured by HoMA-IR [28].
Nuts, which are a well-known source of unsaturated fatty
acids, fiber, antioxidant vitamins, minerals, and other bioac-
tive compounds, are also consumed in high amounts in MD.
Ellagic acid, which is found in significant amounts in nuts, has
been demonstrated to have positive effects on diabetes control
[29]. In addition, plasma values of urolithin A glucuronide,
which is a metabolite of dietary ellagic acid, have been in-
versely correlated with insulin resistance measured by
HoMA-IR [30].
One of the most relevant results of our study was that sub-
jects experienced weight loss without receiving any advice
relating to reducing caloric intake or to modifying their habit-
ual physical activity. This effect could be explained by the low
energy density (defined in terms of available dietary energy
per weight, i.e., energy content/weight of food or kJ/g), ofMD
food components [31, 32]. Furthermore, strict adherence to
MD has also been associated with high fiber intake and high
diet volume (water content) of food. All these mechanisms
lead to a delayed gastric emptying rate and slowed digestion
and absorption which, in turn, slows the rate of glucose ab-
sorption, reduces plasma insulin levels, and elicits earlier sa-
tiety, resulting in a reduction of total caloric intake [33, 34].
Finally, we found an improvement in both systolic and dia-
stolic blood pressures after MD dietary intervention; this pos-
sibly explained by the high mineral content of plant foods,
which tend to reduce arterial blood pressure (including potas-
sium, magnesium, and calcium) [35]. In addition, the high
antioxidant content of plant foods and olive oil may also con-
tribute to the health of the vascular system [36].
Although this study shows promising results, it is not free
of limitations. All the subjects were of Caucasian ethnicity
living in Southern Italy; therefore, our results might not be
capable of extrapolation to other populations with a different
ethnic distribution. Furthermore, the lack of control groups
following other types of diet did not allow for investigation
of what dietary pattern is more effective in the short-term
improvement of metabolic control in prediabetic subjects with
overweight or obesity.
In summary, our study shows that a short-term dietary in-
tervention focused on MD, even not recommending caloric
restriction, in prediabetic subjects with overweight or obesity,
reduced HbA1C values and improved several anthropometric
and metabolic outcomes. We would therefore recommend the
adoption of this nutritional intervention in prediabetes associ-
ated with overweight or obesity. Further studies are needed to
investigate whether there is a beneficial impact of MD on the
long-term risk of developing type 2 diabetes in prediabetic
subjects in different population samples.
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Table 5 Correlation betweenΔHbA1c with energy and nutrient intake
Parameters ΔHbA1c
r P values
Total energy (kcal) 0.955 < 0.001
Protein (g of total kcal) 0.439 0.004
Carbohydrate (g of total kcal) 0.899 < 0.001
Complex (g of total kcal) 0.753 < 0.001
Simple (g of total kcal) 0.921 < 0.001
Fiber (g/day) −0.633 < 0.001
Fat (g of total kcal) 0.922 < 0.001
SFA (g of total kcal) 0.914 < 0.001
MUFA (g of total kcal) −0.469 0.002
PUFA (g of total kcal) 0.371 0.015
n-6 PUFA (g/day) 0.374 0.015
n-3 PUFA (g/day) −0.107 0.498
n-6/n-3 PUFAs ratio 0.393 0.010
Cholesterol (mg/day) 0.899 < 0.001
HbA1c, hemoglobin A1c; SFA, saturated fatty; MUFA, monounsaturated
fatty acids; PUFA, polyunsaturated fatty acids
r=-0.901, p<0.001
Fig. 3 Correlation between delta variation of HbA1c values and delta
variation of PREDIMED score at 4 months of follow-up (r = 0.552,
P < 0.001)
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